Oramed Pharmaceuticals Inc. ORMP
As ofNov 20, 2026, 11:25 AM EST
- YTD
- +27.72%
- 1 year
- +50.41%
Held by funds
41 US ETFs and mutual funds hold ORMP · largest positions
- IWM 0.00% of fund $3.13M
- FSSNX 0.01% of fund $1.90M
- IWN 0.01% of fund $1.17M
- VTWO 0.00% of fund $846.52K
- IWC 0.04% of fund $396.28K
- SILX 0.32% of fund $325.28K
- VALT 0.34% of fund $319.37K
- IJE 0.02% of fund $301.48K
- MDSKX 0.00% of fund $261.46K
- FISVX 0.01% of fund $252.81K
- DFAS 0.00% of fund $237.74K
- GSSC 0.02% of fund $235.18K
- DFAC 0.00% of fund $232.95K
- AVSC 0.01% of fund $205.25K
- VTWV 0.01% of fund $132.34K
- SMMD 0.00% of fund $69.04K
- IWMW* MX 0.00% of fund $46.18K
- DXUV 0.00% of fund $41.18K
- BSMAX 0.00% of fund $39.48K
- DCOR 0.00% of fund $29.77K
Ownership
- Institutions 17.5%
- Insiders 10.6%
- Public and other holders 71.9%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BML Capital Management, LLC | 5.42% | 2,186,191 | 5.20M | Sep 29, 2024 |
| Murchinson Ltd. | 4.24% | 1,708,879 | 4.07M | Sep 29, 2024 |
| Boothbay Fund Management, LLC | 2.05% | 828,331 | 1.97M | Sep 29, 2024 |
| Rathbones Group PLC | 0.72% | 289,803 | 689.73K | Sep 29, 2024 |
| Two Sigma Advisers, LP | 0.63% | 255,600 | 608.33K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.61% | 245,300 | 583.81K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Micro Cap ETF | 0.21% | 84,637 | 201.44K | Oct 30, 2024 |
| SPDR Portfolio Developed World ex-US ETF | 0.12% | 47,512 | 113.08K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 25,455 | 60.58K | Oct 30, 2024 |
| Avantis U.S. Small Cap Equity ETF | 0.04% | 15,439 | 36.74K | Sep 29, 2024 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.03% | 12,544 | 29.85K | Sep 29, 2024 |
| DFA U.S. Targeted Value Portfolio | 0.02% | 7,512 | 17.88K | Jul 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs ORMP, and what each was last paid
Nadav Kidron, President, Chief Executive Officer & Executive ChairmanAverage age 59
| Name | Title | Pay | Age |
|---|---|---|---|
| Nadav Kidron | President, Chief Executive Officer & Executive Chairman | $1.07M | 52 |
| Miriam Kidron | Chief Scientific Officer & Director | $760K | 86 |
| Joshua Hexter | Chief Operating & Business Officer | $583K | 56 |
| Avraham Gabay | Chief Financial Officer, Treasurer & Secretary | $303K | 41 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AGHION DANIEL | Director | Stock Award(Grant) | Jan 29, 2024 | 38,820 |
| GABAY AVRAHAM | Chief Financial Officer | Stock Award(Grant) | Nov 6, 2024 | 170,040 |
| HEXTER JOSHUA | Chairman of the Board | Stock Award(Grant) | Nov 6, 2024 | 511,833 |
| KIDRON MIRIAM | Officer | Stock Award(Grant) | Nov 6, 2024 | 793,666 |
| KIDRON NADAV | Chief Executive Officer | Stock Award(Grant) | Nov 6, 2024 | 1,952,100 |
| MAYER ARIE PH.D. | Director | Stock Award(Grant) | Jan 3, 2024 | 96,134 |
